Clinical trial
Prevention of Akute Kidney Injury With Human Atrial Natriuretic Peptide in Patients Undergoing Heart Transplant.
NCT02665377 is registered in ClinicalTrials.gov with Sahlgrenska University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevention of Akute Kidney Injury With Human Atrial Natriuretic Peptide in Patients Undergoing Heart Transplant.
- Lead sponsor
- Sahlgrenska University Hospital
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 25, 2016
- Completion date
- January 8, 2022
- Enrollment
- 86 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.